— Know what they know.
Not Investment Advice

BPTH OTC

Bio-Path Holdings, Inc.
1W: -40.0% 1M: -98.5% 3M: -99.3% YTD: -99.5% 1Y: -99.6% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±197.0%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $934 mcap · 9M float · 0.359% daily turnover · Short 61% of daily vol

Supply Chain Overview

1 relationships
1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-04-04
Earliest Filing
2024-04-04
Latest Filing
partner: 1

Counterparties (Filed by BPTH)

1 relationships

Companies named in BPTH's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
H.C. Wainwright & Co., LLC — partner Sales agent for the At The Market Offering Agreement 2024-04-04 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-07-16 Unregistered Equity Sales; Bylaws Amendment; Regulation FD; Other Events; Exhibits View
2026-05-26 Regulation FD; Other Events; Exhibits View
2026-02-24 Changes in Control of Registrant; Amendments to Articles of Incorporation or Bylaws; Regulation FD D View
2025-11-14 Departure/Election of Directors; Appointment of Officers; Other Events View
2025-10-29 Departure/Election of Directors; Appointment of Officers View
2025-08-13 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2025-06-24 Departure/Election of Directors; Appointment of Officers; Other Events View
2025-05-02 Other Events; Financial Statements and Exhibits View
2025-04-29 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2025-03-28 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2025-03-28 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-19 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-03-07 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2025-02-18 Notice of Delisting or Transfer View
2025-01-10 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-12-19 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-12-13 Notice of Delisting or Transfer; Departure/Election of Directors; Appointment of Officers; Submissio View
2024-12-12 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-11-25 Other Events; Financial Statements and Exhibits View
2024-11-15 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms